The Quantellect read.As of Nov 19, 2026, 17 active firms cover Zimmer Biomet Holdings Inc: 5 rate it Buy or better, 12 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $90.00 to $115.00, so the covering firms are broadly aligned. The average target of $102.19 sits 1% below the current $103.32. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.07 next quarter toward $8.97 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 active firms
Neutral
Strong Buy00%
Buy529%
Neutral1271%
Sell00%
Strong Sell00%
Based on 17 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$102.19
-1.1% downside
Average target across 16 active firms as of Nov 19, 2026 vs $103.32 current
Highest Target$115.00
Average Target$102.19
Lowest Target$90.00
Detailed analyst forecasts for ZBH
Showing 1–19 of 19 named analysts shown · 17 active firms in the rating projection
As of Nov 19, 2026, 5 of 17 active firms rate ZBH a Buy (12 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ZBH EPS & revenue forecast
EPS · NEXT QUARTER
$2.07
Range $2.00 – $2.18 · 17 analysts · -1% YoY
Next period, 17 analysts expect Zimmer Biomet Holdings Inc to earn $2.07 a share (range $2.00 – $2.18), versus $2.09 a year earlier. Full-year consensus is $8.55, growing to $8.97 the year after.
REVENUE · NEXT QUARTER
$2.1B
Range $2.1B – $2.2B · 17 analysts · +3% YoY
Revenue is expected to reach $2.1B (range $2.1B – $2.2B), +2.9% year-over-year. Full-year consensus is $8.6B, rising to $8.9B next year.
Top analysts covering Zimmer Biomet Holdings Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ZBH.
#1
Joanne Wuensch
Citigroup · Rank #35
Neutral
$117.00+13.2% to target
Overall win rate
51%
+ Follow
#2
JB
Jayson Bedford
Raymond James · Rank #191
Neutral
No targeton ZBH
Overall win rate
44%
+ Follow
#3
Ryan Zimmerman
BTIG · Rank #212
Neutral
No targeton ZBH
Overall win rate
37%
+ Follow
#4
Mike Matson
Needham · Rank #285
Neutral
No targeton ZBH
Overall win rate
36%
+ Follow
#5
Vijay Kumar
Evercore ISI Group · Rank #331
Buy
$110.00+6.5% to target
Overall win rate
36%
+ Follow
ZBH stock forecast FAQ
What is ZBH's average 12-month price target?+
The 16 active firms with a live target average $102.19 for Zimmer Biomet Holdings Inc over the next 12 months, ranging from a $115.00 high to a $90.00 low, as of Nov 19, 2026.
Is ZBH stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 17 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 12 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ZBH?+
The Street-high target is $115.00 (UBS), and the Street-low is $90.00 (Wells Fargo). The average of all 16 active-firm targets is $102.19.
How many active Wall Street firms cover ZBH?+
17 active firms have a recognized rating on Zimmer Biomet Holdings Inc as of Nov 19, 2026, and 16 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ZBH?+
Among analysts who currently cover ZBH, Joanne Wuensch of Citigroup has the strongest overall Quantellect track record (Rank #35). Their current call is Neutral with a $117.00 target.
What is Zimmer Biomet Holdings Inc's projected EPS for next quarter?+
The consensus estimate is $2.07 per share (range $2.00 – $2.18) across 17 analysts. Full-year EPS is projected at $8.55, rising to $8.97 the following year.
How much revenue is Zimmer Biomet Holdings Inc expected to report next quarter?+
Consensus revenue is $2.1B (range $2.1B – $2.2B). Full-year revenue is projected at $8.6B, growing to $8.9B next year.
Have analysts been upgrading or downgrading ZBH lately?+
As of Nov 19, 2026, 5 of 17 active firms rate ZBH a Buy (12 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ZBH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.